Company: CGCT
Filing Date: 2025-03-05
Form Type: S-1/A
Source: 0001104659-25-020969
Chunk: 8

Company: Cartesian Growth Corp III
Filing Date: 2025-03-05
Form: S-1/A
Chunk 8
---
 We expect that our units will be listed on Nasdaq under the symbol “CGCTU”
on or promptly after the date of this prospectus. We expect the Class A ordinary shares and warrants comprising the units to begin
separate trading on the 52 day following the date of this prospectus unless Cantor informs us of its decision to allow
earlier separate trading, subject to our satisfaction of certain conditions as described further herein. Once the securities comprising
the units begin separate trading, we expect that the Class A ordinary shares and warrants will be listed on Nasdaq under the symbols
“CGCT” and “CGCTW,” respectively. However, we cannot guarantee that our securities will be approved for listing
on Nasdaq.

We are an “emerging growth company” and a “smaller reporting company” under applicable federal securities laws and will be subject to reduced public company reporting requirements. Investing in our securities involves a high degree of risk. See “ Risk Factors” beginning on page 39 for a discussion of information that should be considered in connection with an investment in our securities. Investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings.

Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

No offer or invitation, whether directly or indirectly,
is being or may be made to the public in the Cayman Islands to subscribe for any of our securities.

|                            |     | Per Unit |       |     | Total |             |
|:---------------------------|:----|:---------|------:|:----|:------|------------:|
| Public                     
 offering price(1)          |     | $        | 10.00 |     | $     | 200,000,000 |
| Underwriting discounts     
 and commissions            |     | $        |  0.65 |     | $     |  13,000,000 |
| Proceeds, before expenses, 
 to us                      |     | $        |  9.35 |     | $     | 187,000,000 |

| (1) | Includes $0.20 per unit                                                                       
 (excluding any units sold pursuant to the underwriters’ option to purchase additional         
 units), or $4,000,000 in the aggregate (whether or not the underwriters’ option to            
 purchase additional units is exercised